Akbar Molazahi

Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study

Casper Steenholdt, Akbar Molazahi, Mark Ainsworth et al. · Scandinavian Journal of Gastroenterology · 2012 · 92 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease—A Danish Prospective Population-based Cohort Study

Mohamed Attauabi, Anja Poulsen, Klaus Theede et al. · Journal of Crohn s and Colitis · 2020 · 74 citations · Full text

Medicine, Immunology, Internal Medicine +11

Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease

Sine Buhl, Casper Steenholdt, Jørn Brynskov et al. · NEJM Evidence · 2022 · 49 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases – A Danish Prospective Population-Based Cohort Study with Individual-Level Data

Mohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen et al. · Journal of Crohn s and Colitis · 2021 · 18 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +13

Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases

Mohamed Attauabi, C Olgart Hoglund, Janne Fassov et al. · Scandinavian Journal of Gastroenterology · 2021 · 14 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +14